Mechanisms of Exposure Therapy for OCD

Last updated: October 30, 2024
Sponsor: Mclean Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Obsessive-compulsive Disorder

Panic Disorders

Mood Disorders

Treatment

Exposure therapy

Clinical Study ID

NCT06173752
2023P003369
  • Ages 18-65
  • All Genders

Study Summary

Exposure therapy is the most effective treatment available for obsessive compulsive disorder, yet up to 50% of patients do not recover because the mechanisms underlying successful response are poorly understood, leading to significant variability in how clinicians conduct exposure therapy. The main purpose of this study is to determine which target mechanisms are most critical to engage in real-world exposure sessions to produce good treatment outcomes. Adult participants (N = 400) with Obsessive Compulsive Disorder (OCD) receiving exposure therapy from two sites (McLean Hospital, San Diego State University) across the continuum of care (outpatient, partial hospital, residential) will complete baseline clinical and demographic measures as well as weekly symptom reports. The project will measure exposure mechanisms across three levels of analysis (self-report, observer-rated behavior, physiology) during each exposure session. Mechanisms assessed will include a broad range of variables based on both habituation and inhibitory learning models of exposure. Self-report and observer-rated mechanisms will be measured with the Exposure Feedback Form, created and piloted by the study team. Physiological mechanisms will include skin conductance response, heart rate, and heart rate variability measured with a wristwatch. The current study will determine (1) which exposure mechanisms lead to favorable clinical outcomes, and (2) what makes a good exposure for whom. Results of this study have the potential to improve personalized care for the many patients who do not remit following exposure therapy for OCD.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Between the ages of 18-65 years old

  • Seeking exposure treatment at McLean Hospital OCD Institute or San Diego StateUniversity

  • Have a diagnosis of OCD

  • Able to complete study measures and treatment procedures in English

Exclusion

Exclusion Criteria:

  • Acute symptoms of psychosis

  • Active suicidality (plan, means, intent and/or suicide attempt in past 3 months)

  • Presence of co-occurring symptoms that warrant higher level of care (e.g., inpatienttreatment)

  • Presence of any medical, psychiatric, or developmental condition that would preventpatients from completing assessments or exposure exercises (e.g., non-verbal autismspectrum disorder)

Study Design

Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Exposure therapy
Phase:
Study Start date:
October 16, 2024
Estimated Completion Date:
April 30, 2029

Connect with a study center

  • Center for Understanding and Treating Anxiety

    San Diego, California 92120
    United States

    Active - Recruiting

  • McLean OCDI

    Belmont, Massachusetts 02478
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.